Cargando…

Current status of and progress in the treatment of malignant pleural effusion of lung cancer

Malignant pleural effusion (MPE) is a common complication in the late stage of malignant tumors. The appearance of MPE indicates that the primary tumor has spread to the pleura or progressed to an advanced stage. The survival time of the patients will be significantly shortened, with a median surviv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yuhua, Yu, Limeng, Wang, Lili, Wu, Yingxi, Chen, Haiyang, Wang, Qiming, Wu, Yufeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933866/ https://www.ncbi.nlm.nih.gov/pubmed/36818672 http://dx.doi.org/10.3389/fonc.2022.961440

Ejemplares similares

The Riddle of the Sphinx: Progress in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer
por: Zhao, Yuhua, et al.
Publicado: (2023)

Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer
por: Yu, Limeng, et al.
Publicado: (2023)

Malignant pleural effusion: Updates in diagnosis, management and current challenges
por: Addala, Dinesh Narayan, et al.
Publicado: (2022)

Lung adenocarcinoma patients with malignant pleural effusions in hot adaptive immunity status have a longer overall survival
por: Wu, Cheng-Guang, et al.
Publicado: (2022)

Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy
por: Xiang, Zhangqiang, et al.
Publicado: (2022)

A detection panel of novel methylated DNA markers for malignant pleural effusion
por: Liang, Chaonan, et al.
Publicado: (2022)

Double-Stranded DNA in Exosomes of Malignant Pleural Effusions as a Novel DNA Source for EGFR Mutation Detection in Lung Adenocarcinoma
por: Qu, Xueling, et al.
Publicado: (2019)

Case Report: Long-term remission of malignant pleural and peritoneal effusion in a case of advanced lung adenocarcinoma treated with combined crizotinib and anlotinib therapy
por: Tian, Jin, et al.
Publicado: (2023)

Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram
por: Wu, Aihua, et al.
Publicado: (2021)

Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma
por: Choi, Agnes Y., et al.
Publicado: (2022)

Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?
por: Principe, Nicola, et al.
Publicado: (2021)

Total Protein–Chloride Ratio in Pleural Fluid Independently Predicts Overall Survival in Malignant Pleural Effusion at the First Diagnosis
por: Qiao, Xin, et al.
Publicado: (2022)

Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy
por: Li, Qingsong, et al.
Publicado: (2023)

Differentiating malignant and benign pleural effusion in patients with lung cancer: an (18)F-FDG PET/CT retrospectively study
por: Zhang, Weishan, et al.
Publicado: (2023)

Dasatinib-Induced Bilateral Pleural Effusions
por: Rasul, Taha F, et al.
Publicado: (2022)

Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report
por: Rhazari, Meriem, et al.
Publicado: (2022)

Current status and progress in immunotherapy for malignant pleural mesothelioma
por: Sun, Boyang, et al.
Publicado: (2022)

Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion
por: Ai, Ling, et al.
Publicado: (2022)

Diagnostic value of medical thoracoscopy in malignant pleural effusion
por: Wu, Yan-Bing, et al.
Publicado: (2017)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Malignant pleural effusion diagnosis and therapy
por: Yang, Liangliang, et al.
Publicado: (2023)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

Malignant Pleural Effusion and Its Current Management: A Review
por: Skok, Kristijan, et al.
Publicado: (2019)

Malignant Pleural Effusions—A Review of Current Guidelines and Practices
por: Kulandaisamy, Prarthna Chandar, et al.
Publicado: (2021)

Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma
por: Huang, DanHui, et al.
Publicado: (2023)

Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion
por: Verma, Akash, et al.
Publicado: (2016)

Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer
por: Chiang, Chi-Lu, et al.
Publicado: (2022)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study
por: Li, Xin, et al.
Publicado: (2022)

Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis
por: Wang, Cheng-Qiong, et al.
Publicado: (2021)

Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis
por: Gao, Ruiyue, et al.
Publicado: (2019)

Chinese herbal injections versus intrapleural cisplatin for lung cancer patients with malignant pleural effusion: A Bayesian network meta-analysis of randomized controlled trials
por: Xu, Yi-Fang, et al.
Publicado: (2022)

Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor
por: Wang, Jian, et al.
Publicado: (2022)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions
por: Wang, Maoshui, et al.
Publicado: (2014)

Malignant pleural effusions: Differentiating pelvic malignancies
por: Sharma, Mukesh, et al.
Publicado: (2015)

Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion
por: Yokoe, Norihito, et al.
Publicado: (2017)

Indwelling pleural catheters for persistent pleural effusions secondary to post lung resection for malignancies
por: Reinoso, Jean, et al.
Publicado: (2023)

An Update in the Management of Malignant Pleural Effusion
por: Muduly, DK, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_v4c4q5e8keqh4p5o084j0imvbe